Search clinical trials for: GSK372475

Total 4 results

GlaxoSmithKline

Completed

GSK372475 PK Study in Healthy Volunteers

Depressive Disorder

Germany
GlaxoSmithKline

Completed

GSK372475 Bioequivalence Study

Depressive Disorder | Healthy Subjects

Canada
GlaxoSmithKline

Completed

A Study Of New Medicine (GSK 372475) For The Treatment Of Depression

Depressive Disorder

Belgium, Bulgaria, Australia, Canada, Slovakia, Germany, India, France, Finland, Estonia, Poland, South Africa
GlaxoSmithKline

Completed

MDD POC Study GSK372475 Subjects Depressive Disease

Depressive Disorder

Bulgaria, Canada, Chile, Costa Rica, Italy, Germany, India, France, Croatia, Poland

3

Subscribe